On Wednesday, Shares of Wal-Mart Stores, Inc. (NYSE:WMT), lost -10.04% to $60.03. 80.89 million shares of the company were exchanged, after saying earnings will decrease by 6 percent to 12 percent in the fiscal year ending January 2017. The lower guidance surprised analysts, as they were expecting a gain of 4 percent on average for the period, according to data compiled by Bloomberg.
Wal-Mart Stores, Inc. operates retail stores in various formats worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam’s Club. It operates discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, cash and carry stores, home improvement stores, specialty electronics stores, restaurants, apparel stores, drug stores, and convenience stores, in addition to retail Websites, such as walmart.com and samsclub.com.
Shares of Pfizer Inc. (NYSE:PFE), inclined 0.15% to $33.03, during its last trading session.
Pfizer Inc. (PFE) declared it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug Application (sNDA) for XELJANZ® (tofacitinib citrate) for the treatment of adult patients with moderate to severe chronic plaque psoriasis. The Agency offered recommendations specific to the moderate to severe chronic plaque psoriasis sNDA. Pfizer will work with the Agency to determine an appropriate path forward to address their comments, counting providing additional safety analyses of XELJANZ for the projected indication.
Psoriasis affects 7.4 million people in the United States.1 The most common form is plaque psoriasis, which affects about 80 percent of people who have the condition.2a Of those, as many as 20 percent have moderate to severe chronic plaque psoriasis.2b
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
At the end of Wednesday’s trade, Shares of Linear Technology Corporation (NASDAQ:LLTC), inclined 6.22% to $43.72.
Linear Technology Corporation (LLTC), a leading, independent manufacturer of high performance linear integrated circuits, recently stated financial results for the fiscal quarter ended September 27, 2015. Quarterly revenues of $341.9 million for the first quarter of fiscal year 2016 reduced $29.1 million or 7.9% from $371.1 million stated in the first quarter of fiscal year 2015 and reduced $37.6 million or 9.9% from the previous quarter’s revenue of $379.5 million.
Net income of $112.0 million reduced $17.4 million or 13.4% from the first quarter of fiscal year 2015 and reduced $20.7 million or 15.6% from the previous quarter’s net income of $132.7 million. Diluted earnings per share of $0.46 per share in the first quarter of fiscal year 2016 reduced $0.07 per share or 13% from the first quarter of fiscal year 2015 and reduced $0.08 per share or 15% from the fourth quarter of fiscal year 2015. Net income and diluted earnings per share reduced on a sequential basis and from the comparable preceding year period primarily due to the decrease in revenue.
Cash, cash equivalents and marketable securities raised by $42.3 million over the fourth quarter of fiscal year 2015 to $1.24 billion. A cash dividend of $0.30 per share will be paid on November 25, 2015 to stockholders of record on November 13, 2015. During the first quarter the Company generated positive cash flows from operations of $175.7 million or 51% of total revenues. During the first quarter of fiscal year 2016 the Company returned $129.9 million to shareholders in the form of dividends of $73.3 million, representing $0.30 per share, and stock purchases of $56.6 million totaling 1.4 million shares.
Linear Technology Corporation, together with its auxiliaries, designs, manufactures, and markets a line of analog integrated circuits worldwide. The company offers amplifiers, high speed amplifiers, voltage regulators and references, interface circuits, data converters, battery stack monitors, silicon oscillators and Timer Blox, and phase locked loop synthesizers and clock distribution products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
